[Form 4] USANA Health Sciences Inc Insider Trading Activity

Rhea-AI Filing Summary

On 07/24/2025, USANA Health Sciences (USNA) director Frederic J. Winssinger filed a Form 4 showing the conversion of 1,058 restricted stock units (transaction code “M”) into the same number of common shares. The move increased his directly held common stock to 6,929 shares, up from 5,871, an 18% rise. No shares were sold.

Winssinger still owns 3,172 RSUs that vest in four equal 25 % tranches on 24 Jul 2025, 23 Oct 2025, 22 Jan 2026 and 23 Apr 2026. The filing lists a zero exercise price, typical for RSU settlement, and contains no additional corporate events or financial data. While modest, an insider increasing holdings is generally viewed as a constructive signal rather than a liquidity event.

Insights

Securities Analyst

TL;DR – Minor insider buy; positive signal but immaterial to valuation.

Insider purchases, even small, tend to be read positively because they align management with shareholders. Here, a director added only 1,058 shares, lifting his stake to 6,929 shares (<≈0.03 % of USNA’s float, based on last 2024 10-K). There was no open-market purchase; it is an RSU conversion, so cash did not leave the insider’s pocket. Still, he chose to hold, not sell, implying confidence. From a materiality standpoint, the dollar value is limited and unlikely to influence USNA’s fundamentals or liquidity. Therefore, the event is neutral in impact but carries a mild positive signaling effect for sentiment-focused investors.

Insider Trade Summary

1,058 shares exercised/converted

Mixed 2 txns

Insider Winssinger Frederic J

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,058	$0.00	--
Exercise	Common Stock	1,058	$0.00	--

Holdings After Transaction: Restricted Stock Units — 3,172 shares (Direct); Common Stock — 6,929 shares (Direct)

Footnotes (1)

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Winssinger Frederic J

(Last) (First) (Middle)

2944 N 44TH STREET

SUITE 250

(Street)

PHOENIX AZ 85018

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/24/2025		M		1,058	A	(1)	6,929	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/24/2025		M			1,058	(2)	(2)	Common Stock	1,058	$0	3,172	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.